Home

Search

Pathway AI

Account ⋅ Sign Out

Table of contents

Tardive dyskinesia

Key sources
The following summarized guidelines for the management of tardive dyskinesia are prepared by our editorial team based on guidelines from the American Academy of Neurology (AAN 2013).
1

Guidelines

1.Medical management

Switching to atypical antipsychotics: insufficient evidence to support or refute treatment of tardive syndromes by withdrawing causative agents or switching from typical to atypical dopamine receptor blocking agent.
I
Create free account

More topics in this section

  • Clonazepam

  • Risperidone

  • Amantadine and tetrabenazine

  • Agents with no evidence for efficacy